Expression profiles of pancreatic cancer cell lines infected with antisense K-ras-expressing adenoviral vector

Shumpei Ohnami1, Kazunori Aoki, Kimiko Yoshida

  • 1Genetics Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

Insights

K-ras gene mutations are early events in pancreatic cancer. Inhibiting K-ras altered gene expression, identifying potential therapeutic targets like syntaxin 1A and p120 catenin in pancreatic adenocarcinoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • K-ras gene point mutations are frequent in pancreatic adenocarcinoma, indicating their role in early carcinogenesis.
  • The precise impact of K-ras activation on global gene expression in pancreatic cancer remains unclear.

Purpose of the Study:

  • To investigate the molecular cascades triggered by K-ras activation in pancreatic cancer cells.
  • To identify specific genes whose expression is altered due to K-ras mutations.

Main Methods:

  • Utilized adenovirus-mediated antisense K-ras RNA (AxCA-AS) to inhibit K-ras in four pancreatic cancer cell lines.
  • Analyzed global gene expression changes using oligonucleotide microarrays (12,626 genes).
  • Validated microarray findings with real-time RT-PCR and examined gene expression in surgical specimens.

Main Results:

  • Commonly identified 7 up-regulated and 4 down-regulated genes in K-ras-mutated cell lines after AxCA-AS transduction.
  • Syntaxin 1A and p120 catenin isoform were significantly up-regulated in K-ras-mutated pancreatic cancers.
  • RE2 and phenylethanolamine N-methyltransferase showed negligible expression in pancreatic cancers.

Conclusions:

  • K-ras activation influences global gene expression profiles in pancreatic cancer.
  • Syntaxin 1A and p120 catenin isoform up-regulation may be part of K-ras-triggered molecular pathways in pancreatic cancer development.
  • Transcriptional regulation of these genes could be crucial for pancreatic cancer progression.